Kyowa Kirin

Basic Information

• Category: Pharmaceutical Manufacturers
• Founded: 2008
• Headquarters: Tokyo, Japan
• Website: kyowakirin.com

Documented Facts

• Team Size: 669 (No linked source recorded for this statement.)

Evidence and Sources

• Kyowa Kirin — Official Site (official)

Citation Guidance

Explore Pharmaceutical Manufacturers profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Kyowa Kirin.

• Canonical profile: https://brandsource.ai/brands/kyowa-kirin
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/kyowa-kirin/json-ld
• Citation profile API: https://brandsource.ai/api/brands/kyowa-kirin/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (77/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2025-10-28T03:57:46.339Z

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 1 structured fact available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.